Clinical Trials for Acrivon Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Acrivon Therapeutics

Clinical Trials (3)

NCT06667141
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
PHASE1Recruiting
90 participants
Started: Oct 8, 2024 · Completed: Dec 12, 2026
1 condition1 sponsor15 locations
NCT06597565
A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
PHASE2Recruiting
43 participants
Started: Sep 25, 2024 · Completed: Aug 23, 2028
1 condition2 sponsors1 location
NCT05548296
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
PHASE2Recruiting
353 participants
Started: Aug 29, 2022 · Completed: Apr 30, 2027
1 condition2 sponsors69 locations